Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.78 EUR | +0.04% | -0.07% | +94.13% |
12:42pm | Oxford Biomedica Names New Finance Chief | MT |
11:52am | K3 Business sees interim revenue decline | AN |
Business Summary
Number of employees: 464
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cancer Medicines
100.0
%
| 278 | 100.0 % | 238 | 100.0 % | -14.37% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
88.8
%
| 0 | 0.0 % | 211 | 88.8 % | - |
Europe (excluding Germany)
11.2
%
| - | - | 27 | 11.2 % | - |
Asia
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Tim Demuth
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-09-30 |
Julia Neugebauer
IRC | Investor Relations Contact | - | 06-08-31 |
Daniel Palmacci
PRN | Corporate Officer/Principal | - | 20-06-30 |
Ann Merchant
PRN | Corporate Officer/Principal | 59 | 17-12-31 |
Ralf Ostendorp
PRN | Corporate Officer/Principal | - | 98-12-31 |
Corporate Officer/Principal | - | 94-04-30 | |
Klaus de Wall
AUD | Comptroller/Controller/Auditor | - | 05-05-31 |
Corporate Officer/Principal | - | 97-12-31 | |
Human Resources Officer | 54 | 12-05-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Curran
BRD | Director/Board Member | 56 | 19-05-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,716,423 | 2,130,820 ( 5.650 %) | 53,685 ( 0.1423 %) | 5.650 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.84% | 47.96B | |
+2.10% | 42.45B | |
+44.70% | 41.47B | |
+28.67% | 31.6B | |
+22.18% | 28.63B | |
-6.35% | 28.03B | |
+52.07% | 14.56B | |
+49.71% | 14.14B | |
+3.69% | 12.58B |
- Stock Market
- Equities
- MOR Stock
- MOR Stock
- Company MorphoSys AG